Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-007055)

Filing Details

Accession Number:: 0001181431-13-007055
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-06 10:17:44
Reporting Period:: 2013-02-04

Filing Date:: 2013-02-06
Accepted Time:: 2013-02-06 10:17:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
722104	Savient Pharmaceuticals Inc	SVNT	Medicinal Chemicals & Botanical Products (2833)	133033811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1513697	Louis Ferrari	Savient Pharmaceuticals, Inc. 400 Crossing Blvd. Bridgewater NJ 08807	President And Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock $.01 Par Value Per Share	Disposition	2013-02-04	59,000	$1.01	299,571	No	4	S	Direct
Common Stock $.01 Par Value Per Share	Disposition	2013-02-04	3,200	$1.02	296,371	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 1, 2012.